<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01321892</url>
  </required_header>
  <id_info>
    <org_study_id>GCO # 09-0945</org_study_id>
    <nct_id>NCT01321892</nct_id>
  </id_info>
  <brief_title>Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium</brief_title>
  <official_title>Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>William Marsh Rice University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to collect information on whether images made using
      investigational microscopes can improve researchers' ability to evaluate and distinguish
      between normal and abnormal areas in tissue samples surgically removed from patients with
      squamous cell carcinoma. The microscopes being used in this study are considered
      investigational because they have not been approved by the United States Food and Drug
      Administration (FDA) for finding abnormal or pre-cancerous areas.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The overall objective of this exploratory study is to evaluate whether noninvasive
      fluorescence and reflectance imaging of the upper aerodigestive tract can help clinicians
      more accurately determine intraoperative margins during ablative cancer surgery. This is an
      ex vivo study designed to evaluate the feasibility of using prototype optical imaging
      technology to enhance the discrimination between areas of noncancerous &quot;normal&quot; and cancerous
      mucosa. The results of this laboratory study will be used to further refine and develop this
      technology for in vivo application.

      Primary Aim:

      (1) To collect data to develop imaging algorithms to distinguish between normal and cancerous
      upper aerodigestive mucosa.

      Secondary Aims:

        1. To compare the combination of wide-field fluorescence/reflectance and high resolution
           fluorescence microscopy images of upper aerodigestive epithelium to histopathologic
           analysis of biopsied tissue.

        2. To compare the ability of sequential wide-field/fluorescence microscopy imaging to
           discriminate between normal and cancerous oral cavity mucosa with that of white-light
           images obtained after staining with toluidine blue.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy and Interrater Reliability of HRME Image Interpretation</measure>
    <time_frame>baseline</time_frame>
    <description>We will ask blinded raters to classify the HRME images as either benign (normal) or dysplastic/cancerous (abnormal)</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">64</enrollment>
  <condition>Squamous Cell Carcinoma of the Oral Cavity</condition>
  <condition>Oropharynx</condition>
  <condition>Larynx</condition>
  <condition>Hypopharynx</condition>
  <arm_group>
    <arm_group_label>Squamous cell carcinoma</arm_group_label>
    <description>Patients included in this study will be receiving surgical treatment for their biopsy-proven squamous cell carcinoma.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Retained specimens are punch biopsy specimens from the primary tumor resection.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with new head and neck cancer, who reside in the tri-state area.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects with biopsy-proven squamous cell carcinoma of the oral cavity, oropharynx,
             larynx, and/or hypopharynx.

          -  Must be receiving surgical treatment for their cancer.

        Exclusion Criteria:

        â€¢ Presence of medical or psychiatric condition affecting ability to give voluntary,
        informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew Sikora, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mount Sinai School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029-6574</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Blair EA, Callender DL. Head and neck cancer. The problem. Clin Plast Surg. 1994 Jan;21(1):1-7. Review.</citation>
    <PMID>8112003</PMID>
  </reference>
  <reference>
    <citation>Silverman S Jr, Sugerman PB. Oral premalignancies and squamous cell carcinoma. Clin Dermatol. 2000 Sep-Oct;18(5):563-8. Review.</citation>
    <PMID>11134851</PMID>
  </reference>
  <reference>
    <citation>Schwarz RA, Gao W, Daye D, Williams MD, Richards-Kortum R, Gillenwater AM. Autofluorescence and diffuse reflectance spectroscopy of oral epithelial tissue using a depth-sensitive fiber-optic probe. Appl Opt. 2008 Feb 20;47(6):825-34.</citation>
    <PMID>18288232</PMID>
  </reference>
  <reference>
    <citation>Ramanujam N, Mitchell MF, Mahadevan A, Warren S, Thomsen S, Silva E, Richards-Kortum R. In vivo diagnosis of cervical intraepithelial neoplasia using 337-nm-excited laser-induced fluorescence. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10193-7.</citation>
    <PMID>7937860</PMID>
  </reference>
  <reference>
    <citation>Gillenwater A, Jacob R, Richards-Kortum R. Fluorescence spectroscopy: a technique with potential to improve the early detection of aerodigestive tract neoplasia. Head Neck. 1998 Sep;20(6):556-62. Review.</citation>
    <PMID>9702544</PMID>
  </reference>
  <reference>
    <citation>Pavlova I, Weber CR, Schwarz RA, Williams MD, Gillenwater AM, Richards-Kortum R. Fluorescence spectroscopy of oral tissue: Monte Carlo modeling with site-specific tissue properties. J Biomed Opt. 2009 Jan-Feb;14(1):014009. doi: 10.1117/1.3065544.</citation>
    <PMID>19256697</PMID>
  </reference>
  <reference>
    <citation>Epstein JB, Zhang L, Poh C, Nakamura H, Berean K, Rosin M. Increased allelic loss in toluidine blue-positive oral premalignant lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Jan;95(1):45-50.</citation>
    <PMID>12539026</PMID>
  </reference>
  <reference>
    <citation>Epstein JB, Sciubba J, Silverman S Jr, Sroussi HY. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice. Head Neck. 2007 Oct;29(10):948-58. Review.</citation>
    <PMID>17764090</PMID>
  </reference>
  <reference>
    <citation>Martin IC, Kerawala CJ, Reed M. The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Apr;85(4):444-6.</citation>
    <PMID>9574954</PMID>
  </reference>
  <reference>
    <citation>Kerawala CJ, Beale V, Reed M, Martin IC. The role of vital tissue staining in the marginal control of oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2000 Feb;29(1):32-5.</citation>
    <PMID>10691141</PMID>
  </reference>
  <reference>
    <citation>Genden EM, Desai S, Sung CK. Transoral robotic surgery for the management of head and neck cancer: a preliminary experience. Head Neck. 2009 Mar;31(3):283-9. doi: 10.1002/hed.20972.</citation>
    <PMID>18972413</PMID>
  </reference>
  <reference>
    <citation>McNeil BJ, Weichselbaum R, Pauker SG. Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med. 1981 Oct 22;305(17):982-7.</citation>
    <PMID>7278922</PMID>
  </reference>
  <reference>
    <citation>Collier T, Lacy A, Richards-Kortum R, Malpica A, Follen M. Near real-time confocal microscopy of amelanotic tissue: detection of dysplasia in ex vivo cervical tissue. Acad Radiol. 2002 May;9(5):504-12.</citation>
    <PMID>12458875</PMID>
  </reference>
  <reference>
    <citation>Muldoon TJ, Pierce MC, Nida DL, Williams MD, Gillenwater A, Richards-Kortum R. Subcellular-resolution molecular imaging within living tissue by fiber microendoscopy. Opt Express. 2007 Dec 10;15(25):16413-23.</citation>
    <PMID>19550931</PMID>
  </reference>
  <reference>
    <citation>Feuer EJ, Kessler LG. Test statistic and sample size for a two-sample McNemar test. Biometrics. 1989 Jun;45(2):629-36. Erratum in: Biometrics 1989 Sep;45(3):1039.</citation>
    <PMID>2765642</PMID>
  </reference>
  <reference>
    <citation>Rosenberg D, Cretin S. Use of meta-analysis to evaluate tolonium chloride in oral cancer screening. Oral Surg Oral Med Oral Pathol. 1989 May;67(5):621-7.</citation>
    <PMID>2654801</PMID>
  </reference>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2011</study_first_submitted>
  <study_first_submitted_qc>March 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2011</study_first_posted>
  <last_update_submitted>June 20, 2012</last_update_submitted>
  <last_update_submitted_qc>June 20, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 21, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HRME</keyword>
  <keyword>High-resolution microendoscope</keyword>
  <keyword>Optical imaging technology</keyword>
  <keyword>Non-invasive fluorescence and reflectance imaging</keyword>
  <keyword>Upper aerodigestive tract</keyword>
  <keyword>Cancer surgery</keyword>
  <keyword>Squamous cell carcinoma</keyword>
  <keyword>Oral cavity</keyword>
  <keyword>Oropharynx</keyword>
  <keyword>Larynx</keyword>
  <keyword>Hypopharynx</keyword>
  <keyword>Squamous cell carcinoma of the oral cavity, oropharynx, larynx, and/or hypopharynx</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

